Mechanistic explanation for platelet contribution to cancer metastasis

被引:136
作者
Stegner, David
Duetting, Sebastian
Nieswandt, Bernhard [1 ]
机构
[1] Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany
关键词
Tumor metastasis; Cancer; Platelet signaling; Aggregation; Thrombosis; ENDOTHELIAL GROWTH-FACTOR; NATURAL-KILLER-CELLS; EXPERIMENTAL LUNG METASTASIS; AGGREGATION-INDUCING FACTOR; VON-WILLEBRAND-FACTOR; P-SELECTIN; TUMOR-GROWTH; ACTIVATED PLATELETS; BREAST-CANCER; PULMONARY METASTASIS;
D O I
10.1016/S0049-3848(14)50025-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer-associated mortality is frequently caused by metastasis, however, our understanding of this process remains incomplete and therapeutic options are limited. Metastasis is a dynamic multi-step process involving intravasation of tumor cells into the host's blood and lymphatic vessels, their dissemination within the circulation, and finally arrest and extravasation in a distant organ where they establish secondary tumors. It is generally conceived that platelets contribute to all steps of hematogenous tumor dissemination. In this review, we provide an overview of the current knowledge of the platelet receptors involved in tumor cell-induced platelet aggregation, an essential immune surveillance escape mechanism of circulating tumor cells. We discuss how platelets prevent immunological attack, contribute to tumor cell extravasation and thereby facilitate colonization of distant organs. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S149 / S157
页数:9
相关论文
共 153 条
[1]  
ABBASCIANO V, 1995, ONCOLOGY, V52, P381
[2]   Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454 [J].
Amirkhosravi, A ;
Mousa, SA ;
Amaya, M ;
Blaydes, S ;
Desai, H ;
Meyer, T ;
Francis, JL .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (03) :549-554
[3]   Platelet and osteoclast β3 integrins are critical for bone metastasis [J].
Bakewell, SJ ;
Nestor, P ;
Prasad, S ;
Tomasson, MH ;
Dowland, N ;
Mehrotra, M ;
Scarborough, R ;
Kanter, J ;
Abe, K ;
Phillips, D ;
Weilbaecher, KN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14205-14210
[4]   DIFFERING PLATELET AGGREGATING EFFECTS BY 2 TUMOR-CELL LINES - ABSENCE OF ROLE FOR PLATELET-DERIVED ADP [J].
BASTIDA, E ;
ORDINAS, A ;
JAMIESON, GA .
AMERICAN JOURNAL OF HEMATOLOGY, 1981, 11 (04) :367-378
[5]  
BASTIDA E, 1988, HAEMOSTASIS, V18, P29
[6]   TUMOR-CELL-INDUCED PLATELET-AGGREGATION IS A GLYCOPROTEIN-DEPENDENT AND LIPOXYGENASE-ASSOCIATED PROCESS [J].
BASTIDA, E ;
ALMIRALL, L ;
ORDINAS, A .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (06) :760-763
[7]  
BASTIDA E, 1982, CANCER RES, V42, P4348
[8]   Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response [J].
Battinelli, Elisabeth M. ;
Markens, Beth A. ;
Kulenthirarajan, Rajesh A. ;
Machlus, Kellie R. ;
Flaumenhaft, Robert ;
Italiano, Joseph E., Jr. .
BLOOD, 2014, 123 (01) :101-112
[9]  
Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731
[10]   Scientific and therapeutic advances in antiplatelet therapy [J].
Bhatt, DL ;
Topol, EJ .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) :15-28